164 related articles for article (PubMed ID: 22340278)
1. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.
Harrow M; Jobe TH; Faull RN
Psychol Med; 2012 Oct; 42(10):2145-55. PubMed ID: 22340278
[TBL] [Abstract][Full Text] [Related]
2. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
Harrow M; Jobe TH
J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
[TBL] [Abstract][Full Text] [Related]
3. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.
Harrow M; Jobe TH; Faull RN
Psychol Med; 2014 Oct; 44(14):3007-16. PubMed ID: 25066792
[TBL] [Abstract][Full Text] [Related]
4. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up.
Goldberg JF; Harrow M
J Affect Disord; 2004 Aug; 81(2):123-31. PubMed ID: 15306137
[TBL] [Abstract][Full Text] [Related]
5. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
[TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
7. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
Novak Sarotar B; Pesek MB; Agius M; Kocmur M
Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
[TBL] [Abstract][Full Text] [Related]
8. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.
Craig TJ; Grossman S; Mojtabai R; Gibson PJ; Lavelle J; Carlson GA; Bromet EJ
Bipolar Disord; 2004 Oct; 6(5):406-15. PubMed ID: 15383133
[TBL] [Abstract][Full Text] [Related]
11. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
[TBL] [Abstract][Full Text] [Related]
12. A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.
Harrow M; Jobe TH; Faull RN; Yang J
Psychiatry Res; 2017 Oct; 256():267-274. PubMed ID: 28651219
[TBL] [Abstract][Full Text] [Related]
13. Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study.
Kumazaki H; Kobayashi H; Niimura H; Kobayashi Y; Ito S; Nemoto T; Sakuma K; Kashima H; Mizuno M
Compr Psychiatry; 2012 Oct; 53(7):946-51. PubMed ID: 22554765
[TBL] [Abstract][Full Text] [Related]
14. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia.
Harris MS; Reilly JL; Keshavan MS; Sweeney JA
Psychol Med; 2006 Apr; 36(4):485-94. PubMed ID: 16388703
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
Kilian R; Dietrich S; Toumi M; Angermeyer MC
Acta Psychiatr Scand; 2004 Aug; 110(2):108-18. PubMed ID: 15233711
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
18. Choosing antipsychotic maintenance therapy--a naturalistic study.
Tavcar R; Dernovsek MZ; Zvan V
Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
[TBL] [Abstract][Full Text] [Related]
19. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
[TBL] [Abstract][Full Text] [Related]
20. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
